BioCryst Pharmaceuticals, Inc. BCRX

Set alert

8.57 USD 0.00 (+0.00%)

At closeNov 4, 2026, 9:23 AM EST

8.49 -0.08 -0.89%

Pre-market · Nov 4, 9:23 AM ET

8.19 Day range 8.62

6.23 52-week range 11.22

Held by insiders 1.28%

Held by institutions 105.97%

Float held by institutions 107.34%

Institutions 411

Top institutional holders
Holder	% held	Shares	Value	Reported
Blackrock Inc.	9.35%	23,893,036	204.76M	Jun 29, 2026
RA Capital Management, L.P.	6.19%	15,827,186	135.64M	Jun 29, 2026
State Street Corporation	5.94%	15,191,098	130.19M	Jun 29, 2026
Deerfield Management Company, L.P	5.91%	15,096,403	129.38M	Jun 29, 2026
Vanguard Capital Management LLC	4.45%	11,364,236	97.39M	Jun 29, 2026
Vanguard Portfolio Management LLC	4.36%	11,139,158	95.46M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	3.16%	8,067,362	69.14M	Jun 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	2.70%	6,891,002	59.06M	Sep 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.27%	5,791,336	49.63M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund	1.14%	2,911,465	24.95M	Jun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund	1.11%	2,838,097	24.32M	Jun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	0.99%	2,542,173	21.79M	Aug 30, 2026

BCRX insiders
Insider	Relation	Latest transaction	Date	Shares held
BARNES ALANE P	Officer	Sale	May 12, 2026	400,703
DOYLE ANTHONY	Chief Financial Officer	Stock Award(Grant)	Dec 18, 2024	377,867
GALSON STEVEN K	Director	Stock Award(Grant)	Jun 10, 2026	86,165
GAYER CHARLES K	President	Conversion of Exercise of derivative security	Dec 21, 2025	952,583
GHIAS BABAR	Chief Financial Officer	Stock Award(Grant)	Dec 16, 2025	268,700
HUTSON NANCY J	Director	Stock Award(Grant)	Jun 11, 2025	99,138

Held by funds